1. Home
  2. CRVS vs SCSC Comparison

CRVS vs SCSC Comparison

Compare CRVS & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$11.74

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo ScanSource Inc.

SCSC

ScanSource Inc.

HOLD

Current Price

$57.36

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
SCSC
Founded
2014
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2016
1997

Fundamental Metrics

Financial Performance
Metric
CRVS
SCSC
Price
$11.74
$57.36
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$30.17
★ $43.00
AVG Volume (30 Days)
★ 912.0K
202.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.04
21.33
EPS
N/A
★ 3.64
Revenue
N/A
★ $3,846,260,000.00
Revenue This Year
N/A
$2.60
Revenue Next Year
N/A
$4.01
P/E Ratio
★ N/A
$15.87
Revenue Growth
N/A
★ 7.79
52 Week Low
$6.39
$33.76
52 Week High
$26.95
$66.78

Technical Indicators

Market Signals
Indicator
CRVS
SCSC
Relative Strength Index (RSI) 36.59 51.08
Support Level $11.13 $55.00
Resistance Level $13.73 $59.23
Average True Range (ATR) 0.71 1.62
MACD -0.11 -0.11
Stochastic Oscillator 24.05 50.93

Price Performance

Historical Comparison
CRVS
SCSC

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About SCSC ScanSource Inc.

ScanSource Inc is a technology distributor uniquely positioned to address complex, converging technologies and to accelerate growth for channel sales partners across hardware, SaaS, connectivity, and cloud. The Company provides technology solutions and services from suppliers of mobility and barcode, POS, payment terminals, physical security, networking, communications, connectivity, and cloud services to channel sales partners located mainly in the United States and Brazil. It has two reportable segments based on the sales model: Specialty Technology Solutions, which generates maximum revenue and includes hardware, SaaS, and subscription services through a wholesale/resale sales model, and Intelisys & Advisory. Geographically, it derives the majority of its revenue from the United States.

Share on Social Networks: